Simultaneous lesion and brain segmentation in multiple sclerosis using deep neural networks.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
13 01 2021
13 01 2021
Historique:
received:
23
07
2020
accepted:
04
12
2020
entrez:
14
1
2021
pubmed:
15
1
2021
medline:
17
8
2021
Statut:
epublish
Résumé
Segmentation of white matter lesions and deep grey matter structures is an important task in the quantification of magnetic resonance imaging in multiple sclerosis. In this paper we explore segmentation solutions based on convolutional neural networks (CNNs) for providing fast, reliable segmentations of lesions and grey-matter structures in multi-modal MR imaging, and the performance of these methods when applied to out-of-centre data. We trained two state-of-the-art fully convolutional CNN architectures on the 2016 MSSEG training dataset, which was annotated by seven independent human raters: a reference implementation of a 3D Unet, and a more recently proposed 3D-to-2D architecture (DeepSCAN). We then retrained those methods on a larger dataset from a single centre, with and without labels for other brain structures. We quantified changes in performance owing to dataset shift, and changes in performance by adding the additional brain-structure labels. We also compared performance with freely available reference methods. Both fully-convolutional CNN methods substantially outperform other approaches in the literature when trained and evaluated in cross-validation on the MSSEG dataset, showing agreement with human raters in the range of human inter-rater variability. Both architectures showed drops in performance when trained on single-centre data and tested on the MSSEG dataset. When trained with the addition of weak anatomical labels derived from Freesurfer, the performance of the 3D Unet degraded, while the performance of the DeepSCAN net improved. Overall, the DeepSCAN network predicting both lesion and anatomical labels was the best-performing network examined.
Identifiants
pubmed: 33441684
doi: 10.1038/s41598-020-79925-4
pii: 10.1038/s41598-020-79925-4
pmc: PMC7806997
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1087Références
Nat Rev Neurol. 2015 Oct;11(10):597-606
pubmed: 26369511
Neuroimage. 2012 Feb 15;59(4):3774-83
pubmed: 22119648
Magn Reson Imaging. 2012 Nov;30(9):1323-41
pubmed: 22770690
Neuroimage. 2021 Jan 15;225:117471
pubmed: 33099007
Ann Neurol. 1992 Dec;32(6):758-66
pubmed: 1471866
Neuroimage. 2018 Apr 15;170:434-445
pubmed: 28223187
AJNR Am J Neuroradiol. 2017 Feb;38(2):264-269
pubmed: 28059711
Neuroimage Clin. 2020;25:102104
pubmed: 31927500
Med Image Anal. 2013 Jan;17(1):1-18
pubmed: 23084503
J Neurol Sci. 2011 Jun 15;305(1-2):1-10
pubmed: 21463872
JAMA Neurol. 2013 Mar 1;70(3):338-44
pubmed: 23599930
IEEE Access. 2019;7:721-1735
pubmed: 31528523
Ann Neurol. 2018 Feb;83(2):210-222
pubmed: 29331092
Sci Rep. 2018 Sep 12;8(1):13650
pubmed: 30209345
IEEE Trans Med Imaging. 2014 Oct;33(10):1997-2009
pubmed: 24951681
J Neurol. 2018 Jan;265(1):127-133
pubmed: 29159467
Neuroimage Clin. 2019;21:101638
pubmed: 30555005
Eur Radiol. 2019 Mar;29(3):1355-1364
pubmed: 30242503
J Neuroradiol. 2015 Jun;42(3):133-40
pubmed: 25660217
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Front Mol Neurosci. 2018 Dec 17;11:460
pubmed: 30618611
Neuroimage Clin. 2019;21:101593
pubmed: 30502078
Neuroimage. 2017 Jul 15;155:159-168
pubmed: 28435096
J Neural Transm (Vienna). 2017 Dec;124(12):1509-1514
pubmed: 29098451
Invest Radiol. 2019 Jun;54(6):356-364
pubmed: 30829941
Neuroimage Clin. 2020;27:102335
pubmed: 32663798